3.44
price up icon2.38%   0.08
after-market アフターアワーズ: 3.39 -0.05 -1.45%
loading

Envveno Medical Corporation (NVNO) 最新ニュース

pulisher
Jan 05, 2025

enVVeno Medical (NASDAQ:NVNO) and Sharps Technology (NASDAQ:STSS) Head to Head Survey - Defense World

Jan 05, 2025
pulisher
Jan 03, 2025

Insider Buying: Francis Duhay Acquires Shares of enVVeno Medical Corp - GuruFocus.com

Jan 03, 2025
pulisher
Jan 03, 2025

Envveno medical director Robert Gray buys $10,290 in shares - Investing.com India

Jan 03, 2025
pulisher
Jan 03, 2025

Envveno medical director Duhay Francis buys $249,999 in stock By Investing.com - Investing.com Canada

Jan 03, 2025
pulisher
Jan 03, 2025

Envveno medical director Duhay Francis buys $249,999 in stock - Investing.com India

Jan 03, 2025
pulisher
Jan 02, 2025

Envveno medical director Robert Gray buys $10,290 in shares By Investing.com - Investing.com Nigeria

Jan 02, 2025
pulisher
Jan 02, 2025

Insider Buying: Robert Gray Acquires 3,500 Shares of enVVeno Med - GuruFocus.com

Jan 02, 2025
pulisher
Jan 02, 2025

enVVeno Medical Corporation (NASDAQ:NVNO) Director Purchases $10,290.00 in Stock - MarketBeat

Jan 02, 2025
pulisher
Dec 26, 2024

enVVeno Medical Corporation (NASDAQ:NVNO) Director Acquires $15,660.00 in Stock - MarketBeat

Dec 26, 2024
pulisher
Dec 26, 2024

Insider Buying: Sanjay Shrivastava Acquires Shares in enVVeno Me - GuruFocus.com

Dec 26, 2024
pulisher
Dec 26, 2024

Envveno Medical's director Sanjay Shrivastava buys $15,660 in stock - Investing.com

Dec 26, 2024
pulisher
Dec 23, 2024

Insider Buying: Matthew Jenusaitis Acquires 9,620 Shares of enVV - GuruFocus.com

Dec 23, 2024
pulisher
Dec 23, 2024

Envveno medical director Matthew Jenusaitis buys $24,338 in stock By Investing.com - Investing.com Nigeria

Dec 23, 2024
pulisher
Dec 23, 2024

Envveno medical director Matthew Jenusaitis buys $24,338 in stock - Investing.com India

Dec 23, 2024
pulisher
Dec 22, 2024

Critical Survey: enVVeno Medical (NASDAQ:NVNO) versus Profound Medical (NASDAQ:PROF) - Defense World

Dec 22, 2024
pulisher
Dec 20, 2024

NVNO stock touches 52-week low at $2.5 amid market challenges By Investing.com - Investing.com South Africa

Dec 20, 2024
pulisher
Dec 20, 2024

NVNO stock touches 52-week low at $2.5 amid market challenges - Investing.com

Dec 20, 2024
pulisher
Dec 20, 2024

Envveno Medical CEO Robert Berman acquires $30,599 in stock By Investing.com - Investing.com Australia

Dec 20, 2024
pulisher
Dec 19, 2024

CEO Robert Berman Increases Stake in enVVeno Medical Corp with R - GuruFocus.com

Dec 19, 2024
pulisher
Dec 19, 2024

Envveno Medical CEO Robert Berman acquires $30,599 in stock - Investing.com

Dec 19, 2024
pulisher
Dec 16, 2024

enVVeno Medical completes final wave of implants in pre-clinical GLP study - TipRanks

Dec 16, 2024
pulisher
Dec 16, 2024

enVVeno Medical Successfully Completes Final Wave of Implants in Pre-Clinical GLP Study for enVVe - AccessWire

Dec 16, 2024
pulisher
Dec 16, 2024

enVVeno Medical Completes Key Pre-Clinical Study for Revolutionary Venous Valve, Advances FDA Approval Path - StockTitan

Dec 16, 2024
pulisher
Dec 12, 2024

NVNO Stock Touches 52-Week Low at $2.9 Amid Market Challenges - Investing.com

Dec 12, 2024
pulisher
Nov 27, 2024

enVVeno launches recap website highlighting VEITH Symposium participation - TipRanks

Nov 27, 2024
pulisher
Nov 27, 2024

enVVeno Medical Highlights Successful 2024 VEITH Symposium with Launch of Recap Website - Kansas City Star

Nov 27, 2024
pulisher
Nov 27, 2024

enVVeno Medical Showcases Breakthrough VenoValve Trial Data at VEITH Symposium | NVNO Stock News - StockTitan

Nov 27, 2024
pulisher
Nov 27, 2024

NVNO Completes Application for VenoValve's PMA, Shares Likely to Gain - MSN

Nov 27, 2024
pulisher
Nov 27, 2024

enVVeno Medical (NASDAQ:NVNO) Is In A Good Position To Deliver On Growth Plans - Simply Wall St

Nov 27, 2024
pulisher
Nov 25, 2024

Reviewing enVVeno Medical (NASDAQ:NVNO) and Cerus (NASDAQ:CERS) - Defense World

Nov 25, 2024
pulisher
Nov 21, 2024

PMA application submitted for VenoValve device - Venous News

Nov 21, 2024
pulisher
Nov 21, 2024

enVVeno Medical (STU:5HJ) Profitability Rank : 1 (As of Sep. 2024) - GuruFocus.com

Nov 21, 2024
pulisher
Nov 20, 2024

enVVeno Medical rises on submission of the venovalve PMA application for FDA approval - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

One-year data from the VenoValve US pivotal trial emerge - Venous News

Nov 20, 2024
pulisher
Nov 20, 2024

enVVeno Medical to Present Definitive One Year Data from the VenoValve U.S. Pivotal Trial Today at the 51st Annual VEITH Symposium - AccessWire

Nov 20, 2024
pulisher
Nov 20, 2024

enVVeno Medical's VenoValve Trial Shows 85% Success Rate in Pivotal Study | NVNO Stock News - StockTitan

Nov 20, 2024
pulisher
Nov 19, 2024

enVVeno Medical seeks FDA approval for VenoValve - Investing.com India

Nov 19, 2024
pulisher
Nov 19, 2024

enVVeno Medical seeks FDA approval for VenoValve By Investing.com - Investing.com Canada

Nov 19, 2024
pulisher
Nov 19, 2024

enVVeno Medical submits VenoValve PMA application to FDA - TipRanks

Nov 19, 2024
pulisher
Nov 19, 2024

enVVeno Medical Submits the VenoValve PMA Application Seeking FDA Approval - AccessWire

Nov 19, 2024
pulisher
Nov 19, 2024

enVVeno Medical Submits Final FDA Module for VenoValve Breakthrough Device | NVNO Stock News - StockTitan

Nov 19, 2024
pulisher
Nov 19, 2024

Deep Venous Disease Treatment Devices Market 2024-2031 - openPR

Nov 19, 2024
pulisher
Nov 15, 2024

Perceptive Advisors LLC's Strategic Acquisition in enVVeno Medical Corp - GuruFocus.com

Nov 15, 2024
pulisher
Oct 31, 2024

enVVeno Medical (FRA:5HJ) Cyclically Adjusted FCF per Share : €0.00 (As of Jun. 2024) - GuruFocus.com

Oct 31, 2024
medical_devices STE
$204.01
price down icon 0.05%
medical_devices ZBH
$103.56
price down icon 0.87%
medical_devices PHG
$25.45
price up icon 1.15%
$79.88
price down icon 1.47%
$81.72
price up icon 1.49%
medical_devices EW
$73.54
price down icon 0.50%
大文字化:     |  ボリューム (24 時間):